参考文献

［1］ ZHANG L, LONG J, JIANG W, et al. Trends in Chronic Kidney Disease in China [J]. N Engl J Med, 2016, 375 (9): 905-906.

［2］ LONG Y S, ZHENG S, KRALIK P M, et al. Impaired Albumin Uptake and Processing Promote Albuminuria in OVE26 Diabetic Mice [J]. J Diabetes Res, 2016, 2016 (8749417.

［3］ WANG H, FENG Z, XIE J, et al. Podocyte-specific knockin of PTEN protects kidney from hyperglycemia [J]. Am J Physiol Renal Physiol, 2018, 314 (6): F1096-f1107.

［4］ LIU Y, LI L, QIU M, et al. Renal and cerebral RAS interaction contributes to diabetic kidney disease [J]. Am J Transl Res, 2019, 11 (5): 2925-2939.

［5］ GEMBARDT F, BARTAUN C, JARZEBSKA N, et al. The SGLT2 inhibitor empagliflozin ameliorates early features of diabetic nephropathy in BTBR ob/ob type 2 diabetic mice with and without hypertension [J]. Am J Physiol Renal Physiol, 2014, 307 (3): F317-325.

［6］ NAMMO T, UDAGAWA H, FUNAHASHI N, et al. Genome-wide profiling of histone H3K27 acetylation featured fatty acid signalling in pancreatic beta cells in diet-induced obesity in mice [J]. Diabetologia, 2018, 61 (12): 2608-2620.